First Heartland Consultants’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-846
Closed -$243K 288
2019
Q1
$243K Buy
+846
New +$245K 0.07% 230
2018
Q4
Sell
-838
Closed -$230K 246
2018
Q3
$230K Buy
+838
New +$218K 0.07% 226
2017
Q4
Sell
-1,107
Closed -$210K 287
2017
Q3
$210K Buy
+1,107
New +$211K 0.05% 315
2015
Q3
Sell
-1,279
Closed -$210 264
2015
Q2
$210 Buy
+1,279
New +$204K 0.06% 236

Other funds holding ELV

First Heartland Consultants's ELV Position: Q2 2019 in Review

First Heartland Consultants sold out of Elevance Health (ELV) in Q2 2019, closing a stake of 846 shares — an estimated $243K sold.

First Heartland Consultants first reported a position in ELV in Q2 2015 and held it in 4 quarters. The position peaked at $243K in Q1 2019. 1,030 funds tracked by Wall St. Rank hold ELV as of Q2 2019.

  • First Heartland Consultants reported no remaining Elevance Health position as of Q2 2019 after selling out during the quarter.
  • First Heartland Consultants sold 846 Elevance Health shares in Q2 2019, an estimated $243K.
  • First Heartland Consultants first reported a position in Elevance Health in Q2 2015 and held it in 4 quarters.
  • First Heartland Consultants's Elevance Health position peaked at $243K in Q1 2019.
  • 1,030 funds tracked by Wall St. Rank held Elevance Health as of Q2 2019.

Based on First Heartland Consultants's 13F filing for Q2 2019, filed 12 Aug 2019.